Zhejiang Shapuaisi Pharmaceutical (603168.SH): Olodaterol hydrochloride eye drops obtained drug registration certificate
Shapuaisi (603168.SH) announced that the company has received approval from the National Medical Products Administration for the issuance of hydrochloride...
Zhejiang Shapuaisi Pharmaceutical (603168.SH) announced that the company has received the Drug Registration Certificate for Olopatadine Hydrochloride Eye Drops approved and issued by the National Medical Products Administration. The approved Olopatadine Hydrochloride Eye Drops are used to treat eye itching related to allergic conjunctivitis.
Related Articles
HK Stock Market Move |
Huachuang Securities: Small and medium-sized brokerages still possess cyclical elasticity, and product capability determines development space.
HK Stock Market Move | Shenzhen Longsys Electronics (09976) rose over 7% in early trading, with a net profit exceeding 10 billion in the first half of the year. The company is a leading domestic memory module manufacturer.
HK Stock Market Move |
Huachuang Securities: Small and medium-sized brokerages still possess cyclical elasticity, and product capability determines development space.
HK Stock Market Move | Shenzhen Longsys Electronics (09976) rose over 7% in early trading, with a net profit exceeding 10 billion in the first half of the year. The company is a leading domestic memory module manufacturer.
RECOMMEND
